Monday, October 07, 2013 7:50:47 AM
I thought of that as well. Given they can delay the actual FDA results, there is still no reason to come out with other information including what their preliminary results showed from the Association they are working with - or what stage they are in ie: have completed the trials, the report from the Trial Company indicating the effectiveness of the product, a goal for the production and/or selling of the product, promotions for the product etc. While awaiting final approval, there should be no delay in other, equally important information, coming out. IMHO anyway.
Recent ESSI News
- Eco Science Solutions Integrates IDScan.net's DIVE Into Herbo Pay to Power Identity Verification, Compliance, and Fraud Prevention • InvestorsHub NewsWire • 03/27/2026 04:01:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/12/2026 11:12:40 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2026 07:42:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/04/2026 08:08:40 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/09/2025 08:53:56 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 09/15/2025 05:13:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 06/16/2025 04:15:19 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 05/15/2025 04:00:00 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 05/01/2025 10:05:08 AM
